| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alkyltransferase-like proteins
|
Margison, Geoffrey P.
|
|
2007
|
6 |
8 |
p. 1222-1228
7 p.
|
article
|
| 2 |
DNA binding, nucleotide flipping, and the helix-turn-helix motif in base repair by O 6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapy
|
Tubbs, Julie L.
|
|
2007
|
6 |
8 |
p. 1100-1115
16 p.
|
article
|
| 3 |
Editorial Board
|
|
|
2007
|
6 |
8 |
p. CO2-
1 p.
|
article
|
| 4 |
Genetic association and functional studies of major polymorphic variants of MGMT
|
Bugni, James M.
|
|
2007
|
6 |
8 |
p. 1116-1126
11 p.
|
article
|
| 5 |
Human variants of O 6-alkylguanine-DNA alkyltransferase
|
Pegg, Anthony E.
|
|
2007
|
6 |
8 |
p. 1071-1078
8 p.
|
article
|
| 6 |
Live and let die: In vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection
|
Milsom, Michael D.
|
|
2007
|
6 |
8 |
p. 1210-1221
12 p.
|
article
|
| 7 |
Lung cancer risk and variation in MGMT activity and sequence
|
Povey, Andrew C.
|
|
2007
|
6 |
8 |
p. 1134-1144
11 p.
|
article
|
| 8 |
Methylation damage response in hematopoietic progenitor cells
|
Casorelli, Ida
|
|
2007
|
6 |
8 |
p. 1170-1178
9 p.
|
article
|
| 9 |
MGMT: A personal perspective
|
Mitra, Sankar
|
|
2007
|
6 |
8 |
p. 1064-1070
7 p.
|
article
|
| 10 |
MGMT hypermethylation: A prognostic foe, a predictive friend
|
Jacinto, Filipe V.
|
|
2007
|
6 |
8 |
p. 1155-1160
6 p.
|
article
|
| 11 |
MGMT inhibitors—The Trinity College–Paterson Institute experience, a chemist's perception
|
McMurry, T. Brian H.
|
|
2007
|
6 |
8 |
p. 1161-1169
9 p.
|
article
|
| 12 |
MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents
|
Kaina, Bernd
|
|
2007
|
6 |
8 |
p. 1079-1099
21 p.
|
article
|
| 13 |
Novel role of triazenes in haematological malignancies: Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia
|
Caporaso, Patrizia
|
|
2007
|
6 |
8 |
p. 1179-1186
8 p.
|
article
|
| 14 |
O6-methylguanine-DNA methyltransferase deficiency in developing brain: Implications for brain tumorigenesis
|
Bobola, Michael S.
|
|
2007
|
6 |
8 |
p. 1127-1133
7 p.
|
article
|
| 15 |
O6-methylguanine-DNA-methyltransferase (MGMT) gene therapy targeting haematopoietic stem cells: Studies addressing safety issues
|
Sorg, Ursula R.
|
|
2007
|
6 |
8 |
p. 1197-1209
13 p.
|
article
|
| 16 |
Preface
|
Kaina, Bernd
|
|
2007
|
6 |
8 |
p. 1063-
1 p.
|
article
|
| 17 |
Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals
|
Hansen, Ryan J.
|
|
2007
|
6 |
8 |
p. 1145-1154
10 p.
|
article
|
| 18 |
Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells
|
Schambach, Axel
|
|
2007
|
6 |
8 |
p. 1187-1196
10 p.
|
article
|
Journal description